Adalimumab Drug Levels at Secondary Loss of Response Do Not Predict Response to Dose-intensification in Crohn's Disease: A Retrospective, International Multicenter Study.
Inflammatory bowel diseases（2023）
摘要
Drug levels following dose-intensification rather than at the time of secondary loss of response were associated with subsequent CD remission.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要